Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes. Issue 1 (24th August 2018)

• Record Type: Journal Article
• Authors: Neyman, Anna; Nelson, Jennifer; Tersey, Sarah A.; Mirmira, Raghavendra G.; Evans‐Molina, Carmella; Sims, Emily K.
• Is Part Of: Diabetes, obesity & metabolism. Volume 21:Issue 1(2019)
• Page Start: 95
• Page End: 102
• Publication Date: 2018-08-24
• Subjects: beta cell function -- type 1 diabetes; Diabetes -- Periodicals; Obesity -- Periodicals; Metabolism -- Disorders -- Periodicals; Clinical pharmacology -- Periodicals; 616.462
• DOI: 10.1111/dom.13489
• Languages: English
• ISSNs: 1462-8902

Abstract

Abstract : Aim: To evaluate whether β cells continue to undergo death in the later stages of type 1 diabetes (T1D). Materials and Methods: Fasting banked sera from a cross‐section of 90 participants in the T1D Exchange Registry with longstanding T1D (median duration of 9 years) were analysed. Subjects were determined to be C‐peptide (−) or (+) based on mixed‐meal tolerance testing. Results were compared with 54 adult non‐diabetic controls. Stimulated samples were assayed in a subset of subjects. Levels of unmethylated and methylated preproinsulin ( INS ) DNA were analysed using digital droplet PCR. Results: Fasting and stimulated circulating unmethylated INS DNA levels were increased among both C‐peptide (−) and C‐peptide (+) subjects with longstanding T1D compared with non‐diabetic controls ( P < 0.01). Consistent with prior reports, unmethylated INS DNA values correlated with methylated INS DNA values, which were also elevated among T1D subjects ( P < 0.001). There was wide variation in the effects of mixed‐meal stimulation on DNA levels, with fasting values in the highest quartiles decreasing with stimulation ( P < 0.05). Conclusions: These results could reflect ongoing β cell death in individuals with longstanding T1D, even in the absence of detectable C‐peptide production, suggesting that therapies targeting β cell survival could be beneficial among individuals with longstanding T1D.